[Federal Register Volume 77, Number 80 (Wednesday, April 25, 2012)] [Notices] [Pages 24719-24720] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2012-9935] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Secondary Review The meeting announced below concerns Grants for Injury Control Research Centers, Funding Opportunity Announcement (FOA) CE12-001, secondary review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP: Time and Date: 1 p.m.-3 p.m., May 31, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. Matters To Be Discussed: The meeting will include the secondary review and discussion [[Page 24720]] of competitive applications following initial review of applications received in response to ``FOA CE12-001, Grants for Injury Control Research Centers (R49).'' Contact Person for More Information: Christine Morrison, Ph.D., Director, Extramural Research Program Office, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway, NE., Mailstop F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4233. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 18, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012-9935 Filed 4-24-12; 8:45 am] BILLING CODE 4163-18-P